Rosiglitazone increases cerebral Klotho expression to reverse baroreflex in type 1-like diabetic rats

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Li Jen ^a   Cheng, Meng Fu ^a   Ku, Po Ming ^b   Lin, Jia Wei ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KLOTHO PROTEIN; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RECOMBINANT KLOTHO PROTEIN; RECOMBINANT PROTEIN; ROSIGLITAZONE; STREPTOZOCIN; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA GLUCURONIDASE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; HEART RATE VARIABILITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDULLA OBLONGATA; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANIMAL; BLOOD; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; BAROREFLEX; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLUCURONIDASE; HEART RATE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MEDULLA OBLONGATA; RATS, WISTAR; RECOMBINANT PROTEINS; STREPTOZOCIN; THIAZOLIDINEDIONES;

EID: 84896120214     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/309151     Document Type: Article

References (48)

1. Kawasaki R., Tanaka S., Tanaka S., Abe S., Sone H., Yokote K., Ishibashi S., Katayama S., Ohashi Y., Akanuma Y., Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. Ophthalmology 2013 120 3 574 582 10.1016/j.ophtha.2012.08.029
2. Ko S. H., Ko S. H., Letter: diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients (diabetes metab j 2011,35:390-6). Diabetes and Metabolism Journal 2011 35 5 558 560 10.4093/dmj.2011.35.5.558
3. El-Menyar A. A., Dysrhythmia and electrocardiographic changes in diabetes mellitus: pathophysiology and impact on the incidence of sudden cardiac death. Journal of Cardiovascular Medicine 2006 7 8 580 585 2-s2.0-33748449300 10.2459/01.JCM.0000237904.95882.c8 (Pubitemid 44350492)
4. La Rovere M. T., Pinna G. D., Hohnloser S. H., Marcus F. I., Mortara A., Nohara R., Bigger J. T. Jr., Camm A. J., Schwartz P. J., Barorefiex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001 103 16 2072 2077 2-s2.0-0035942099 (Pubitemid 32373010)
5. Silvani A., Magosso E., Bastianini S., Lenzi P., Ursino M., Mathematical modeling of cardiovascular coupling: central autonomic commands and baroreflex control. Autonomic Neuroscience 2011 162 1-2 66 71 2-s2.0-79958016962 10.1016/j.autneu.2011.04.003
6. Frattola A., Parati G., Gamba P., Paleari F., Mauri G., Di Rienzo M., Castiglioni P., Mancia G., Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997 40 12 1470 1475 2-s2.0-0031465166 10.1007/s001250050851 (Pubitemid 28004942)
7. Eckberg D. L., Harkins S. W., Fritsch J. M., Baroreflex control of plasma norepinephrine and heart period in health subjects and diabetic patients. Journal of Clinical Investigation 1986 78 2 366 374 2-s2.0-0022516124 (Pubitemid 16074072)
8. Fazan R. Jr., Dias Da Silva V. J., Ballejo G., Salgado H. C., Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats. Journal of Hypertension 1999 17 4 489 495 2-s2.0-0032989842 10.1097/00004872-199917040-00006 (Pubitemid 29308558)
9. Chen H. Y., Wu J. S., Chen J. J., Cheng J. T., Impaired regulation function in cardiovascular neurons of nucleus tractus solitarii in streptozotocin-induced diabetic rats. Neuroscience Letters 2008 431 2 161 166 2-s2.0-38349019490 10.1016/j.neulet.2007.11.035
10. Guimaraes P. S., Santiago N. M., Xavier C. H., Velloso E. P., Fontes M. A., Santos R. A., Campagnole-Santos M. J., Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. American Journal of Physiology 2012 303 H393 H400 10.1152/ajpheart.00075. 2012
11. Kar S., Gao L., Belatti D. A., Curry P. L., Zucker I. H., Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 2011 58 4 627 634 2-s2.0-80053556070 10.1161/ HYPERTENSIONAHA.111.177600
12. do Carmo J. M., Hall J. E., da Silva A. A., Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. American Journal of Physiology 2008 295 5 H1974 H1981 2-s2.0-57049099914 10.1152/ajpheart.00265.2008
13. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A., Shiraki-Iida T., Nishikawa S., Nagai R., Nabeshima Y., Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997 390 6655 45 51 2-s2.0-0030724491 10.1038/36285 (Pubitemid 27494749)
14. Xu C., Song R. J., Yang J., Jiang B., Wang X. L., Wu W., Zhang W., Klotho gene polymorphism of rs3752472 is associated with the risk of urinary calculi in the population of Han nationality in Eastern China. Gene 2013 526 2 494 497 10.1016/j.gene.2013.06.001
15. Wang H. L., Xu Q., Wang Z., Zhang Y. H., Si L. Y., Li X., Yang Q., Xiao H., A potential regulatory single nucleotide polymorphism in the promoter of the Klotho gene may be associated with essential hypertension in the Chinese Han population. Clinica Chimica Acta 2010 411 5-6 386 390 2-s2.0-75049085781 10.1016/j.cca.2009.12.004
16. Tangri N., Alam A., Wooten E. C., Huggins G. S., Lack of association of Klotho gene variants with valvular and vascular calcification in Caucasians: a candidate gene study of the Framingham Offspring Cohort. Nephrology Dialysis Transplantation 2011 26 12 3998 4002 2-s2.0-82255194301 10.1093/ndt/gfr188
17. Zhang F., Zhai G., Kato B. S., Hart D. J., Hunter D., Spector T. D., Ahmadi K. R., Association between KLOTHO gene and hand osteoarthritis in a female Caucasian population. Osteoarthritis and Cartilage 2007 15 6 624 629 2-s2.0-34248587172 10.1016/j.joca.2006.12.002 (Pubitemid 46760616)
18. Freathy R. M., Weedon M. N., Melzer D., Shields B., Hitman G. A., Walker M., McCarthy M. I., Hattersley A. T., Frayling T. M., The functional "KL-VS" variant of KLOTHO is not associated with type 2 diabetes in 5028 UK Caucasians. BMC Medical Genetics 2006 7 51 2-s2.0-33746937807 10.1186/1471-2350-7-51 (Pubitemid 44202761)
19. Kawano K., Ogata N., Chiano M., Molloy H., Kleyn P., Spector T. D., Uchida M., Hosoi T., Suzuki T., Orimo H., Inoue S., Nabeshima Y., Nakamura K., Kuro-O M., Kawaguchi H., Klotho gene polymorphisms associated with bone density of aged postmenopausal women. Journal of Bone and Mineral Research 2002 17 10 1744 1751 2-s2.0-0036785320
20. Imura A., Iwano A., Tohyama O., Tsuji Y., Nozaki K., Hashimoto N., Fujimori T., Nabeshima Y., Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Letters 2004 565 1-3 143 147 2-s2.0-2342610541 10.1016/j.febslet.2004.03. 090 (Pubitemid 38595335)
21. Zhang H., Li Y., Fan Y., Wu J., Zhao B., Guan Y., Chien S., Wang N., Klotho is a target gene of PPAR- γ Kidney International 2008 74 6 732 739 2-s2.0-50849091263 10.1038/ki.2008.244
22. Zhang Y., Guan Y., PPAR- γ agonists and diabetic nephropathy. Current Diabetes Reports 2005 5 6 470 475 2-s2.0-29644432906 10.1007/s11892-005-0057-5
23. Guan Y., Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. Journal of the American Society of Nephrology 2004 15 11 2801 2815 2-s2.0-16644377741 10.1097/01.ASN.0000139067.83419.46 (Pubitemid 41103389)
24. Ohga S., Shikata K., Yozai K., Okada S., Ogawa D., Usui H., Wada J., Shikata Y., Makino H., Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF- B activation. American Journal of Physiology 2007 292 4 F1141 F1150 2-s2.0-34147213227 10.1152/ajprenal.00288.2005 (Pubitemid 46578056)
25. Sommer M., Wolf G., Rosiglitazone increases PPAR γ in renal tubular epithelial cells and protects against damage by hydrogen peroxide. American Journal of Nephrology 2007 27 4 425 434 2-s2.0-34447545820 10.1159/000105125 (Pubitemid 47077207)
26. Huang K. C., Cherng Y. G., Chen L. J., Hsu C. T., Cheng J. T., Rosiglitazone is effective to improve renal damage in type-1-like diabetic rats. Hormone and Metabolic Research 2013
27. Chang K. S., Lund D. D., Alterations in the baroreceptor reflex control of heart rate in streptozotocin diabetic rats. Journal of Molecular and Cellular Cardiology 1986 18 6 617 624 2-s2.0-0022588855 (Pubitemid 16090718)
28. Cheng J. T., Huang C. C., Liu I.-M., Tzeng T. F., Chang C. J., Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006 55 3 819 825 2-s2.0-33644767124 (Pubitemid 43343242)
29. Liu G. Y., An Z. M., Protective effect of rosiglitazone sodium on islet b-cell of stz induced diabetic rats through jnk pathway. Journal of Sichuan University 2009 40 3 430 434 2-s2.0-67649973538
30. Tikellis C., Jandeleit-Dahm K. A., Sheehy K., Murphy A., Chin-Dusting J., Kling D., Sebokova E., Cooper M. E., Mizrahi J., Woollard K. J., Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Atherosclerosis 2008 199 1 55 64 2-s2.0-45449114246 10.1016/j.atherosclerosis. 2007.10.038
31. Kim E. K., Miller I., Aja S., Landree L. E., Pinn M., McFadden J., Kuhajda F. P., Moran T. H., Ronnett G. V., C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. Journal of Biological Chemistry 2004 279 19 19970 19976 2-s2.0-2442631468 10.1074/jbc.M402165200 (Pubitemid 38623439)
32. Oliveira D. R., Santos R. A. S., Santos G. F. F., Khosla M. C., Campagnole-Santos M. J., Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension 1996 27 6 1284 1290 2-s2.0-0030004176 (Pubitemid 26165632)
33. Valenti V. E., Ferreira C., Meneghini A., Ferreira M., Murad N., Ferreira Filho C., Correa J. A., De Abreu L. C., Colombari E., Evaluation of baroreflex function in young spontaneously hypertensive rats. Arquivos Brasileiros de Cardiologia 2009 92 3 210 215 2-s2.0-65949111719 10.1590/S0066-782X2009000300009
34. Valenti V. E., Imaizumi C., De Abreu L. C., Colombari E., Sato M. A., Ferreira C., Intra-strain variations of baroreflex sensitivity in young Wistar-Kyoto rats. Clinical and Investigative Medicine 2009 32 6 E251 E257 2-s2.0-73249121100
35. Wang Y., Sun Z., Current understanding of klotho. Ageing Research Reviews 2009 8 1 43 51 2-s2.0-57749190558 10.1016/j.arr.2008.10.002
36. Kamemori M., Ohyama Y., Kurabayashi M., Takahashi K., Nagai R., Furuya N., Expression of Klotho protein in the inner ear. Hearing Research 2002 171 1-2 103 110 2-s2.0-0036768613 10.1016/S0378-5955(02)00483-5 (Pubitemid 36158688)
37. Takeshita K., Fujimori T., Kurotaki Y., Honjo H., Tsujikawa H., Yasui K., Lee J., Kamiya K., Kitaichi K., Yamamoto K., Ito M., Kondo T., Iino S., Inden Y., Hirai M., Murohara T., Kodama I., Nabeshima Y., Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 2004 109 14 1776 1782 2-s2.0-2342599742 10.1161/01.CIR.0000124224. 48962.32 (Pubitemid 38500681)
38. Saito Y., Yamagishi T., Nakamura T., Ohyama Y., Aizawa H., Suga T., Matsumura Y., Masuda H., Kurabayashi M., Kuro-O M., Nabeshima Y., Nagai R., Klotho protein protects against endothelial dysfunction. Biochemical and Biophysical Research Communications 1998 248 2 324 329 2-s2.0-0032551734 10.1006/bbrc.1998.8943 (Pubitemid 28386420)
39. De Angelis K., Irigoyen M. C., Morris M., Diabetes and cardiovascular autonomic dysfunction: application of animal models. Autonomic Neuroscience 2009 145 1-2 3 10 2-s2.0-58149457373 10.1016/j.autneu.2008.10.013
40. Malik M., Bigger J. T. Jr., Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. European Heart Journal 1996 17 3 354 381 10.1093/ oxfordjournals.eurheartj.a014868
41. Maeda C. Y., Fernandes T. G., Timm H. B., Irigoyen M. C., Autonomic dysfunction in short-term experimental diabetes. Hypertension 1995 26 6 1100 1104 2-s2.0-0028799454
42. Gamboa J., Blankenship D. A., Niemi J. P., Landreth G. E., Karl M., Hilow E., Sundararajan S., Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion. Neuroscience 2010 170 3 846 857 2-s2.0-77956504399 10.1016/j.neuroscience.2010. 07.063
43. Breidert T., Callebert J., Heneka M. T., Landreth G., Launay J. M., Hirsch E. C., Protective action of the peroxisome proliferator-activated receptor- γ agonist pioglitazone in a mouse model of Parkinson's disease. Journal of Neurochemistry 2002 82 3 615 624 2-s2.0-0036326074 10.1046/j.1471-4159.2002.00990.x (Pubitemid 34831499)
44. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., Greenberg J. H., A peroxisome proliferator-activated receptor- γ agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005 36 2 353 359 2-s2.0-12844281747 10.1161/01.STR.0000152271.21943.a2 (Pubitemid 40170822)
45. Park S., Yi J., Miranpuri G., Satriotomo I., Bowen K., Resnick D. K., Vemuganti R., Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1002 1012 2-s2.0-33847093475 10.1124/jpet.106.113472 (Pubitemid 46294061)
46. Shuaib A., The role of taurine in cerebral ischemia: studies in transient forebrain ischemia and embolic focal ischemia in rodents. Advances in Experimental Medicine and Biology 2003 526 421 431 2-s2.0-1542673205
47. Zhang H. L., Xu M., Wei C., Qin A. P., Liu C.-F., Hong L.-Z., Zhao X.-Y., Liu J., Qin Z.-H., Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor- B signaling pathway. Neuroscience 2011 176 381 395 2-s2.0-79851512032 10.1016/j.neuroscience.2010.12.029
48. Fong W. H., Tsai H. D., Chen Y. C., Wu J. S., Lin T. N., Anti-apoptotic actions of ppar- γ against ischemic stroke. Molecular Neurobiology 2010 41 2-3 180 186 2-s2.0-77955085757 10.1007/s12035-010-8103-y